$1.170
-0.496 (-42.36%)At close
- High
- 1.610
- Open
- 1.560
- VWAP
- 1.31
- Volume
- 4.61M
- Mkt Cap
- —
- Low
- 1.160
- Amount
- 6.05M
- EV/EBITDA, TTM
- 0.00
PomDoctor Ltd is a holding company principally engaged in the operation of online medical services platform for chronic diseases. The Company operates its businesses through two segments. The Internet Hospital segment includes providing online follow-up consultations and online prescription renewal service to customers and also sells prescription to customers through the website and apps. The Pharmaceutical Supply Chain segment includes pharmacy retail sales and wholesale. The Company mainly conducts its business in the domestic market.
AI analysis of PomDoctor Ltd (POM)
SellPomDoctor Ltd is not a good buy right now due to significant financial instability and declining stock performance. The current price is 0.63, with a staggering year-to-date change of -89.23%. Additionally, the company has a forward P/E ratio of 0, indicating no expected profitability in the near future. The main risk is the gross margin which has decreased to 13.66%, reflecting ongoing profitability pressures.
Valuation Metrics
Events Timeline
News
8.510-19PRnewswirePomdoctor Terminates ADR Program, Lists on Nasdaq
- 8.510-12PRnewswire
Pomdoctor Advances Predictive Healthcare Transformation
- 8.510-09PRnewswire
Pomdoctor Faces Nasdaq Delisting Risk Due to Low Share Price
- 7.509-30PRnewswire
Pomdoctor Advances AI Chronic Disease Management System
7.509-30NewsfilterPomdoctor Advances AI Chronic Disease Management System
POM FAQ — answered by Alphio AI
PomDoctor Ltd is a holding company principally engaged in the operation of online medical services platform for chronic diseases. The Company operates its businesses through two segments. The Internet Hospital segment includes providing online follow-up consultations and online prescription renewal service to customers and also sells prescription to customers through the website and apps. The Pharmaceutical Supply Chain segment includes pharmacy retail sales and wholesale. The Company mainly conducts its business in the domestic market. It operates in the Healthcare sector.
PomDoctor Ltd is not a good buy right now due to significant financial instability and declining stock performance. The current price is 0.63, with a staggering year-to-date change of -89.23%. Additionally, the company has a forward P/E ratio of 0, indicating no expected profitability in the near future. The main risk is the gross margin which has decreased to 13.66%, reflecting ongoing profitability pressures.
Community
More ↗No posts yet
Sign up or log in to join the discussionThis page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.